Pharmaceuticals, Biotechnology and Life Sciences
Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, reported net revenue $5.6 million for the third quarter 2015.
Vishnu Chemicals has reappointed of Ch. Krishna Murthy, Chairman & Managing Director for a period of 5 years
Swiss-based Roche plans to exit four manufacturing sites globally. Workforce reduction is imminent.
Akers Biosciences has appointed Raza Bokhari M.D. as a Non-executive Director of the company.
Silence Therapeutics plc, a London-headquartered drug development company, dealing with the delivery of novel RNA interference (RNAi) therapeutics for the treatment…
Horizon Pharma about Express Scripts’ business practices: “Express Scripts… also operates its own mail-order pharmacy and thus is a direct competitor of small, independent specialty pharmacies”
Horizon Pharma on Wednesday announced a collaboration with the Alliance for Lupus Research (ALR) to study RAYOS (prednisone) delayed-release tablets in systemic lupus erythematosus (SLE).
Biofrontera has announced that there have been no new operational developments or matters which have arisen in relation to the ongoing approval processes or other operational aspects of the Company.
Long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart disease.
Diplomat Pharmacy, NYSE-listed pharmaceutical company, will dispense Cotellic in combination with the BRAF inhibitor Zelboraf to treat patients with advanced melanoma that cannot be removed by surgery, or that has spread from the primary site.